Received Sep 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19-2 | COVID19 (COVID19 (MODERNA BIVALENT)) | MODERNA | UNK | — | — |
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) in a 74-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The patient's past medical history included CAPD (CAPD (dialysis)) since an unknown date. Concurrent medical conditions included Type I diabetes mellitus. On 15-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In January 2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced VOMITING (Vomiting). In January 2023, VOMITING (Vomiting) had resolved. No concomitant medications were provided. It was reported that patient had taken all Covid vaccines since 2021 till now, which was 7-8 vaccines. It was reported that at each time almost 10 hours after the vaccine she would start vomiting every 20 to 30 minutes and this would last for 6-8 hours. The patient received the Moderna COVID-19 vaccine in 2021. On 28-Apr-2022, patient received a 0.5 mL dose of the Moderna COVID-19 Vaccine Booster. Patient had other 4 vaccines (Spikevax NOS), but she had no information about them. It was mentioned that she had diabetes type 1 and was on dialysis (CAPD). No treatment medication was provided. This case was linked to MOD-2025-789725 (Patient Link).
CAPD (CAPD (dialysis)); Type I diabetes mellitus